Literature DB >> 8393306

Malignant degeneration of pleomorphic adenoma--clinical implications.

S W Duck1, F M McConnel.   

Abstract

INTRODUCTION: The incidence of carcinoma arising in a pleomorphic adenoma is reportedly between 1.4% and 6.3%. Malignant degeneration is often associated with a prolonged history of untreated or recurrent pleomorphic adenoma.
MATERIALS AND METHODS: Two patients with malignant parotid carcinoma that arose from benign pleomorphic adenoma are reviewed.
RESULTS: Both patients exhibited a prolonged history of pleomorphic adenoma apparently persistent after initial inadequate surgery. Surgeries were performed 37 and 12 years before development of malignancy. DISCUSSION: The phenomenon of malignant carcinoma arising from benign pleomorphic adenoma is an important issue. The occurrence of these malignant carcinomas emphasizes that aggressive treatment of primary and recurrent mixed tumors is necessary.

Entities:  

Mesh:

Year:  1993        PMID: 8393306     DOI: 10.1016/0196-0709(93)90026-4

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  6 in total

1.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

Review 2.  [Epidemiology, diagnosis, and treatment of giant pleomorphic adenomas of the parotid gland].

Authors:  H Maier; S Frühwald; M Tisch; B Danz; K J Lorenz
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

3.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

4.  The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients.

Authors:  H Leverstein; R M Tiwari; G B Snow; J E van der Wal; I van der Waal
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 3.236

5.  Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.

Authors:  Ana Amélia de Souza; Albina Altemani; Ney Soares de Araujo; Lucas Novaes Texeira; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Clin Pathol       Date:  2019-09-26

Review 6.  Giant pleomorphic adenoma of the parotid gland: an unusual case presentation and literature review.

Authors:  A Tarsitano; A Pizzigallo; F Giorgini; C Marchetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-10       Impact factor: 2.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.